|
|
 |

Fish Oil Offers Hope For Sufferers of Bipolar Disorder
Fish Oil May Work Better Than Drugs
Bipolar disorder is a severe mental illness involving repeat episodes of manic-depression, wild mood swings, hyperactivity and in many cases excessive cheerfulness. As with so many other mental illnesses the prescribed remedy usually includes large amounts of drugs namely lithum carbonate or valproate to name just a few. While drugs offer some relief for those suffering with bipolar disorder they are not always effective and recurrence rates are very high notwithstanding regular medication.
Many in the medical community believe that bipolar disorder in part is caused by an overactivity in the neuronal pathways of the brain. Omega-3 fatty acids have been shown to dampen this overactivity. Based on this theory the hypothesis has been advanced that omega-3 fatty acides (EPA and DHA) may be useful in treating bipolar disorder. Medical scientists have recently confirmed the validity of this theory in a study just completed at the Harvard Medical School.
The double-blind, placebo-controlled study conducted at Harvard Medical School included 30 patients (both men and women) who all having been diagnosed with bipolar disorder. Half the study participants were administered seven fish oil capsules twice a day while the placebo group were given seven olive oil capsules twice a day. Each fish oil capsule contained 440 mg of eicosapentaenoic acid and 240 mg of docosahexaenoic acid. All of the participants except four in the fish oil group and four in the placebo group also continued to receive a standard mood-stabilizing drug prescribed previously. The mental state of the participants was measured using four scales (Clinical Global Impression Scale, Global Assessment Scale, Young Mania Rating Scale, and the Hamilton Rating Scale for Depression) at the start of the study and after two, four, six, eight, twelve and sixteen weeks. Twelve of the 14 participants in the fish oil group were able to complete the 4 month trail without experiencing any major episodes of mania or depression as compared to only six out of 16 participants in the placebo group. An important observation was that while nine of the placebo group members experienced worsening depression none of the fish oil group members did. The four patients who had not been prescribed mood-stabilizing drugs but had been taking the fish oil completed the study without major episodes, but only one member in the placebo group not on mood-stabilizing drugs did.
The average decline in depression rating on the Hamilton Scale was almost 50 per cent in the fish oil group as compared to an increase of 25 per cent in the control group. The Harvard researchers urge further trials of fish oils in the treatment of depression and manic-depressive illness.
A number of references in this text were taken from the following sources:
Stoll, Andrew L., et al. Omega 3 fatty acids in bipolar disorder. Archives of General Psychiatry, Vol. 56, May 1999, pp. 407-12 and pp. 415-16 (commentary)
Calabrese, Joseph R., et al. Fish oils and bipolar disorder. Archives of General Psychiatry, Vol. 56, May 1999, pp. 413-14 (commentary)
** The information and the claims made on this website are not approved to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Please view our full Terms of Use Agreement for more information and the terms and conditions governing your use of this site.
|